Clinical Trials Directory

Trials / Completed

CompletedNCT02332304

Amniotic Fluid Optical Density Determination as a Test for Assessment of Fetal Lung Maturity.

Amniotic Fluid Optical Density Determination Between 28 and 36 6/7 Weeks of Pregnancy and Its Relationship With the Diagnosis of Neonatal Respiratory Distress Syndrome.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Saint Thomas Hospital, Panama · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

To determine the relationship between the result of amniotic fluid optical density between 26 and 36 6/7 weeks of pregnancy and the risk of developing neonatal respiratory distress syndrome.

Conditions

Interventions

TypeNameDescription
PROCEDUREPreterm fetusA sample of amniotic fluid was taken before the birth of fetus between 26 and 36 6/7 weeks of pregnancy.

Timeline

Start date
2014-05-01
Primary completion
2014-11-01
Completion
2014-12-01
First posted
2015-01-06
Last updated
2015-01-06

Locations

1 site across 1 country: Panama

Source: ClinicalTrials.gov record NCT02332304. Inclusion in this directory is not an endorsement.

Amniotic Fluid Optical Density Determination as a Test for Assessment of Fetal Lung Maturity. (NCT02332304) · Clinical Trials Directory